Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 2
2004 4
2005 7
2006 6
2007 2
2008 8
2009 4
2010 7
2011 11
2012 12
2013 4
2014 12
2015 15
2016 25
2017 26
2018 23
2019 8
2020 13
2021 23
2022 24
2023 19
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

237 results

Results by year

Filters applied: . Clear all
Page 1
Quantifying hospital-associated costs, and accompanying travel costs and productivity losses, before and after withdrawing tumour necrosis factor-alfa inhibitors in juvenile idiopathic arthritis.
Florax AA, Doeleman MJH, de Roock S, van der Linden N, Schatorjé E, Currie G, Marshall DA, IJzerman MJ, Yeung RSM, Benseler SM, Vastert SJ, Wulffraat NM, Swart JF, Kip MMA; for UCAN-CAN DU and UCAN CURE consortia. Florax AA, et al. Among authors: ijzerman mj. Rheumatology (Oxford). 2023 Dec 20:kead688. doi: 10.1093/rheumatology/kead688. Online ahead of print. Rheumatology (Oxford). 2023. PMID: 38123516
A tailored approach to horizon scanning for cancer medicines.
Soon JA, To YH, Alexander M, Trapani K, Ascierto PA, Athan S, Brown MP, Burge M, Haydon A, Hughes B, Itchins M, John T, Kao S, Koopman M, Li BT, Long GV, Loree JM, Markman B, Meniawy TM, Menzies AM, Nott L, Pavlakis N, Petrella TM, Popat S, Tie J, Xu W, Yip D, Zalcberg J, Solomon BJ, Gibbs P, McArthur GA, Franchini F, IJzerman M. Soon JA, et al. Among authors: ijzerman m. J Cancer Policy. 2023 Dec;38:100441. doi: 10.1016/j.jcpo.2023.100441. Epub 2023 Nov 20. J Cancer Policy. 2023. PMID: 38008488 Free article.
Patient and healthcare professional acceptability of pharmacogenetic screening for DPYD and UGT1A1: A cross sectional survey.
Glewis S, Krishnasamy M, Lingaratnam S, Harris S, Underhill C, Georgiou C, Warren M, Campbell R, IJzerman M, Fagery M, Campbell I, Martin JH, Tie J, Alexander M, Michael M. Glewis S, et al. Among authors: ijzerman m. Clin Transl Sci. 2023 Dec;16(12):2700-2708. doi: 10.1111/cts.13664. Epub 2023 Oct 31. Clin Transl Sci. 2023. PMID: 37877594 Free PMC article.
Cost Effectiveness of Molecular Diagnostic Testing Algorithms for the Treatment Selection of Frontline Ibrutinib for Patients with Chronic Lymphocytic Leukemia in Australia.
Vu M, Degeling K, Thompson ER, Blombery P, Westerman D, IJzerman MJ. Vu M, et al. Among authors: ijzerman mj. Appl Health Econ Health Policy. 2024 Jan;22(1):107-122. doi: 10.1007/s40258-023-00826-4. Epub 2023 Aug 22. Appl Health Econ Health Policy. 2024. PMID: 37608228 Free PMC article.
237 results